Charting a course for genomic sequencing in patient care

Doctor with a young patient in a hospital bed In the nearly four years since its launch, the Clinical Sequencing Exploratory Research (CSER) program has made significant strides in defining the role of genomics in medicine. CSER is nearing the end of its first round of research awards. To help identify the direction of a potential follow-up program, CSER investigators and colleagues recently met in Bethesda, Maryland, for a one-day conference, Integrating Genomic Sequencing into Clinical Care: CSER and Beyond. Read more

New study finds genomic risk factors for juvenile arthritis

Dan Kastner Systemic juvenile idiopathic arthritis (sJIA) is a potentially life-threatening childhood disease, characterized by persistent joint swelling, pain and stiffness. Now, NHGRI Scientific Director Daniel Kastner, M.D., Ph.D., and his fellow investigators and colleagues have identified genomic variants that confer at least a two-fold increased risk of sJIA, suggesting a role for certain immune system genes in disease development. The results appeared in the Nov. 23 Proceedings of the National Academy of Sciences Early Edition. Read more

Join NHGRI in celebrating Family Health History Day!

Since 2004, the U.S. Surgeon General has recognized Thanksgiving as National Family Health History Day. This year, the National Human Genome Research Institute (NHGRI), along with Surgeon General Vice Admiral Vivek H. Murthy, M.D., M.B.A., encourages families to personalize their healthcare by sharing their family health history, and tracking illnesses from one generation to the next. Read more
Watch the video on YouTube

Video now available
Newborn Screening

The Newborn Sequencing in Genomic Medicine and Public Health (NSIGHT) Program Webinar

On Wednesday, Nov. 18, four teams from the Newborn Sequencing in Genomic Medicine and Public Health (NSIGHT) program presented research updates via a live, public webinar. NSIGHT explores the use of genome sequencing information during the newborn period. For more information and to view webinar videos, go to: Webinar Agenda

TCGA study reveals new clues to the genomic diversity of prostate cancer

Read more New findings on prostate cancer may enable doctors to make better diagnoses and prognoses for patients and provide novel directions for therapies, according to a study from The Cancer Genome Atlas (TCGA) Network. Investigators published the in-depth analysis of 333 prostate cancer tumors online November 5, 2015 in Cell. TCGA is jointly supported and managed by the National Human Genome Research Institute and the National Cancer Institute, both parts of the National Institutes of Health. Read more

View Highlights Archive | Get RSS Feed

For You
Quick Links